Researchers Investigate a Muscle Protein Linked to Insulin Resistance in Type 2 Diabetes
Exercise-related changes in Miro1 may help explain how physical activity improves glucose regulation.
Medical Xpress reported on 19 October that researchers identified Miro1 as a possible contributor to insulin resistance in skeletal muscle. In experimental models, removing the protein improved insulin responsiveness, while exercise was associated with lower muscle Miro1 levels in people with type 2 diabetes.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Insulin resistance occurs when cells respond less effectively to insulin, making it harder for the body to move glucose from the bloodstream into tissues. Skeletal muscle is particularly important because it accounts for a substantial portion of the body's glucose use after meals.
The study investigated Miro1, a protein found at elevated levels in skeletal muscle from people with type 2 diabetes. Researchers reported that removing the protein restored aspects of insulin responsiveness in experimental models. They also observed lower Miro1 levels after aerobic exercise in participants with obesity and type 2 diabetes, alongside improved insulin sensitivity.
These findings provide a possible explanation for some of the metabolic benefits of exercise and may help identify future therapeutic targets. They do not mean that a Miro1-targeting medicine is available or that exercise alone cures diabetes.
People with diabetes should continue their prescribed medicines, appropriate nutrition and activity plans, and regular monitoring. Those using insulin or other medicines that can cause low blood sugar should ask their healthcare team how to exercise safely.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
